Biogen, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Biogen, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4439
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Biogen, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Biogen, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Biogen, Inc. (Biogen or ‘the company’) formerly known as Biogen Idec, is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of therapies in the areas of hematology, neurology and immunology. The company’s key products include Tecfidera, Tysabri (natalizumab), Avonex (Interferon beta-1a) and Rituxan (rituximab). The company primarily operates in the US and Europe. Biogen is headquartered in Weston, Massachusetts, the US.

Scope

- Detailed information on Biogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Biogen, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Biogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Biogen, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Biogen, Inc.: Company Overview 9
Biogen, Inc.: Overview and Key Facts 9
Biogen, Inc.: Overview 9
Biogen, Inc.: Key Facts 9
Biogen, Inc.: Key Employees 11
Biogen, Inc.: Key Employee Biographies 13
Biogen, Inc.: Major Products and Services 19
Biogen, Inc.: Company History 21
Biogen, Inc.: Management Statement 27
Biogen, Inc.: Locations and Subsidiaries 32
Biogen, Inc.: Key Competitors 33
Biogen, Inc.: Company Analysis 34
Biogen, Inc.: Business Description 34
Biogen, Inc.: SWOT Analysis 36
Biogen, Inc.: SWOT Overview 36
Biogen, Inc.: Strengths 36
Biogen, Inc.: Weaknesses 37
Biogen, Inc.: Opportunities 37
Biogen, Inc.: Threats 39
Biogen, Inc.: Corporate Financial Deals Activity 40
Biogen, Inc.: Financial Deals Overview 40
Biogen, Inc.: Targets and Partners 42
Biogen, Inc.: Top Deals 2014 – 2018YTD* 44
Biogen, Inc.: Advisors 45
Biogen, Inc.: Top Financial Advisors 45
Biogen, Inc.: Mergers and Acquisitions 46
Biogen, Inc.: Corporate Venturing 47
Biogen, Inc.: Partnership 48
Biogen, Inc.: Divestments 49
Biogen, Inc.: Recent Developments 50
Biogen, Inc.: News and Events Summary 50
Biogen, Inc.: Business Expansion 54
Biogen, Inc.: Contracts 54
Biogen, Inc.: Financial Deals 55
Biogen, Inc.: Financial Performance 55
Biogen, Inc.: Grants 56
Biogen, Inc.: Market Developments 56
Biogen, Inc.: Strategy and Operations 57
Appendix 58
Contact Us 58
Methodology 58
About MarketLine 59

List of Tables
Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Locations and Subsidiaries
Table 4: Biogen, Inc.: Key Competitors
Table 5: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Biogen, Inc.: M&A Activity by Geography (TTM*)
Table 7: Biogen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Biogen, Inc.: Targets and Partners
Table 10: Biogen, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Biogen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Biogen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Biogen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Biogen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Biogen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Biogen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Biogen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Biogen, Inc.: News and Events Summary
Table 20: Biogen, Inc.: Business Expansion
Table 21: Biogen, Inc.: Contracts
Table 22: Biogen, Inc.: Financial Deals
Table 23: Biogen, Inc.: Financial Performance
Table 24: Biogen, Inc.: Grants
Table 25: Biogen, Inc.: Market Developments
Table 26: Biogen, Inc.: Strategy and Operations

List of Figures
Figure 1: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Biogen, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Biogen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Biogen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Biogen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Biogen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Biogen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Biogen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Biogen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Biogen, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Range Resources Corp (RRC)-石油・ガス分野:企業M&A・提携分析
    Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and gas properties in the Appalachian basin and Northern Louisiana of the US. Range’s natural gas and …
  • Oando Plc (OANDO):石油・ガス:M&Aディール及び事業提携情報
    Summary Oando Plc (Oando) is a provider of integrated energy solutions to the oil and gas industry. Through its subsidiaries, the company explores for and produces oil and gas through the acquisition of rights in oil blocks on the Nigerian continental shelf and deep offshore. It has producing, devel …
  • Magma Fincorp Limited:企業のM&A・事業提携・投資動向
    Magma Fincorp Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Magma Fincorp Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Perusahaan Gas Negara (Persero) Tbk (PGN) is a downstream energy that transmits and distributes natural gas. The company plans, constructs and develops downstream natural gas businesses and carries out processing, transportation, storage and trading of natural gas. It produces, trades and …
  • Gamida Cell Ltd:企業のM&A・事業提携・投資動向
    Gamida Cell Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gamida Cell Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • AB Science SA (AB):企業の財務・戦略的SWOT分析
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • ImaBiotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary ImaBiotech SAS (ImaBiotech) is a contract research organization that provides mass spectrometry imaging services. The organization offers software products such as multimaging and quantinetix. Its service portfolio includes consulting and training, biomarker discovery, pharmaco-kinetics and …
  • Grasim Industries Ltd (GRASIM):企業の財務・戦略的SWOT分析
    Grasim Industries Ltd (GRASIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • NeoDynamics AB:製品パイプライン分析
    Summary NeoDynamics AB (NeoDynamics) is an independent medical technology company that focuses on the development of medical solutions for the quick detection and treatment of cancer. It is developing the NeoNavia biopsy system that helps collect samples from breast lesions or axillary lymph nodes f …
  • Brambles Limited (BXB):企業の財務・戦略的SWOT分析
    Brambles Limited (BXB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Spritzer Bhd:企業の戦略・SWOT・財務分析
    Spritzer Bhd - Strategy, SWOT and Corporate Finance Report Summary Spritzer Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Boule Diagnostics AB (BOUL)-医療機器分野:企業M&A・提携分析
    Summary Boule Diagnostics AB (Boule) is a medical device company that develops, manufactures and markets blood counting systems. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. Its products include blood cell counter and instruments, reag …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Seneca Biopharma Inc (CUR):企業の財務・戦略的SWOT分析
    Summary Seneca Biopharma Inc(Seneca) formerly known as Neuralstem Inc, is a biopharmaceutical company that develops novel treatments for nervous system diseases. The company offers cell therapy treatment for ALS, ischemic stroke, spinal cord injury, multiple sclerosis, optic neuritis, Alzheimer’s di …
  • ICICI Bank Ltd:戦略・SWOT・企業財務分析
    ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Alstom SA (ALO)-エネルギー分野:企業M&A・提携分析
    Summary Alstom SA (Alstom) is a manufacturer of transportation vehicles. It designs, develops and manufactures rail transport equipment, systems, services and signaling for urban, suburban, regional and main line passenger transportation, and for freight transportation. The company offers a wide ran …
  • Singapore Technologies Engineering Ltd (S63):企業の財務・戦略的SWOT分析
    Singapore Technologies Engineering Ltd (S63) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Mahanagar Telephone Nigam Ltd (MTNL):企業の財務・戦略的SWOT分析
    Mahanagar Telephone Nigam Ltd (MTNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mesa Air Group, Inc.:企業の戦略・SWOT・財務分析
    Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Beactica AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Beactica AB (Beactica) is a drug discovery company develops a pipeline of novel and mechanistically defined small molecule therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate ana …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆